SEC 13F Intelligence

Rock Springs Capital Management LP / MRTXEUR

Rock Springs Capital Management LP’s Mirati Therapeutics Inc Position

Does Rock Springs Capital Management LP own Mirati Therapeutics Inc (MRTXEUR)? Not currently — the last reported position was 835.8K shares worth $49M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$49M
Q4 2023
Shares
835.8K
% of Portfolio
+1.21%
Quarters Held
21
position exited

Position History MRTXEUR

Reported value by quarter
Q4 ’18: $6MQ4 ’18Q1 ’19: $13MQ2 ’19: $21MQ3 ’19: $20MQ3 ’19Q4 ’19: $39MQ1 ’20: $26MQ2 ’20: $40MQ2 ’20Q3 ’20: $58MQ4 ’20: $82MQ1 ’21: $55MQ1 ’21Q2 ’21: $52MQ3 ’21: $63MQ4 ’21: $60MQ4 ’21Q1 ’22: $46MQ2 ’22: $57MQ3 ’22: $61MQ3 ’22Q4 ’22: $36MQ1 ’23: $40MQ2 ’23: $41MQ2 ’23Q3 ’23: $49MQ4 ’23: $49Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 2023835.8K$49M+1.21%
Q3 20231.13M$49M+1.32%
Q2 20231.12M$41M+0.96%
Q1 20231.07M$40M+0.94%
Q4 2022805.0K$36M+0.88%
Q3 2022866.8K$61M+1.56%
Q2 2022845.0K$57M+1.65%
Q1 2022559.7K$46M+1.16%
Q4 2021410.4K$60M+1.39%
Q3 2021353.5K$63M+1.31%
Q2 2021319.1K$52M+1.02%
Q1 2021323.6K$55M+1.21%
Q4 2020373.2K$82M+1.74%
Q3 2020348.8K$58M+1.47%
Q2 2020348.8K$40M+1.09%
Q1 2020341.5K$26M+1.09%
Q4 2019300.0K$39M+1.22%
Q3 2019257.5K$20M+0.80%
Q2 2019202.5K$21M+0.75%
Q1 2019180.0K$13M+0.51%
Q4 2018150.0K$6M+0.30%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rock Springs Capital Management LP’s full portfolio or all institutional holders of MRTXEUR.